Calcipotriol Solution for the Treatment of Scalp Psoriasis: Evaluation of Efficacy, Safety and Acceptance in 3,396 Patients

Publisher： Karger

E-ISSN： 1421-9832|203|2|153-156

ISSN： 1018-8665

Source： Dermatology, Vol.203, Iss.2, 2001-09, pp. : 153-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Combined High-Dose Treatment with Calcipotriol Ointment and Solution in Patients with Psoriasis

By  

Dermatology, Vol. 204, Iss. 3, 2002-05 ,pp. : 214-221

Karger

Access to resources Recommend Favorite

A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis

By  

Dermatology, Vol. 217, Iss. 4, 2008-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

Calcipotriol plus Betamethasone Dipropionate Scalp Formulation Is Effective and Well Tolerated in the Treatment of Scalp Psoriasis: A Phase II Study

By  

Dermatology, Vol. 217, Iss. 2, 2008-05 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

By  

Dermatology, Vol. 213, Iss. 4, 2006-12 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

Efficacy of Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol for the Treatment of Psoriasis vulgaris: A Randomised, Double-Blind Trial

By  

Dermatology, Vol. 209, Iss. 4, 2004-12 ,pp. : 308-313

Karger

Access to resources Recommend Favorite